The fund in question is CAGE — the Avantis CIBC All-Equity Asset Allocation ETF, launched on the Toronto Stock Exchange in March 2026. It is a collaboration between CIBC Asset Management and Avantis Investors, an arm of American Century Investments that has grown to more than $125 billion in assets under management. CAGE is structured as a single-ticket all-equity fund, similar in format to familiar products like VEQT, but with an explicit tilt toward small-cap and value stocks rather than pure market-cap weighting. Avantis has suggested the tilt could add as much as 2% per year over a plain market-cap fund. If true, that would be a significant edge. The question is whether "if true" is doing most of the work in that sentence.
What Factor Tilts Actually Promise
Factor investing rests on a plausible idea: certain stock characteristics — being smaller, cheaper relative to book value, or more profitable — have historically been associated with different return patterns than the broad market. Academic researchers have documented these patterns across long time horizons and multiple markets. The logic is that investors who systematically overweight these characteristics might capture a return premium over time.
The critical word is might. Factor premiums are not guaranteed payments; they are risk premiums — compensation for bearing a specific type of risk or for the discomfort of holding something that can lag the market for extended, unpredictable stretches. Allocating to factors can lead to significant tracking errors, and periods of relative underperformance compared to the broader market are inevitable, sometimes continuing uninterrupted for several years. An investor in a factor-tilted fund could watch a plain market-cap ETF outperform for the better part of a decade before — or without — the tilt eventually paying off.
This is not a flaw unique to CAGE. It is a structural feature of factor investing that no fund design can eliminate. The academic case for factor premiums explicitly requires a long-term investment horizon, because factors earn their return premiums over the long run, not in any predictable short window.
The Practical Tradeoffs Side by Side
Before treating a product launch as evidence that a strategy works, it helps to map the tradeoffs honestly.
| Dimension | Market-cap ETF (e.g., VEQT) | Factor-tilted all-in-one (e.g., CAGE) |
|---|---|---|
| Expected return story | Match the market, minus a low fee | Plausible premium over market, minus a higher fee |
| Fee drag | Very low management expense | Higher than plain passive; fee gap narrows the claimed edge |
| Tracking error | Closely follows global market index | Can deviate materially from market for years |
| Structural simplicity | Straightforward to explain and hold | Requires understanding why the tilt exists and trusting it |
| Emotional tolerance needed | Moderate — rides market cycles | Higher — must endure lagging a simpler alternative |
| Evidence of durable real-world benefit | Strong long-run data for broad market ownership | Academically grounded but not guaranteed at any horizon |
The fee comparison matters more than it might first appear. If the theoretical factor premium is 2% and the additional management cost of the factor fund versus a plain passive alternative is, say, 0.3–0.5%, the net advantage narrows before the first trade is made. Then tracking error and investor behavior further erode any edge. The question is not whether the strategy is theoretically sound but whether a real investor, holding a real fund through real periods of underperformance, will actually capture what the theory promises.
From Headline to Decision: A Framework
It is useful to have a way of moving from a product’s marketing claim to a disciplined evaluation. The diagram below outlines that process.
flowchart LR A[Marketing claim:\nfactor tilt adds ~2%/yr] --> B[What is the evidence?\nAcademic, long-horizon,\nnot guaranteed] B --> C[What can go wrong?\nFee drag, tracking error,\nyears of underperformance] C --> D[Can I survive the failure?\nWill I hold when strategy lags?] D --> E[Decision:\nSimplicity or complexity?]
The first step is identifying what the claimed edge actually is and where it comes from. In CAGE’s case, the story is academically grounded — small-cap and value tilts have genuine research support. That is worth acknowledging. But research support is not the same as a reliable near-term outcome. One commentator familiar with the fund put it plainly: the fund is great news for DIY investors wanting a factor-tilted all-in-one, but the theoretical outperformance is skepticism-worthy, and personally enduring periods where the factors "aren’t working" would be a real test.
The second step is estimating what can go wrong. Factor strategies can trail the market for three, five, or more years. That is not a catastrophic scenario — it is a normal one. The investor who switches to a plain market-cap fund after four years of underperformance has locked in the worst of both worlds: paid higher fees during the lag, and abandoned the strategy before any potential payoff.
The third step — and the one most frequently skipped — is an honest self-assessment of behavioral survivability. The right fund is often the one an investor can hold through weak periods without changing their plan. That is not a consolation prize for choosing simplicity; it is a genuine performance variable. A theoretically superior strategy that gets abandoned in year three produces inferior results.
Why Simplicity Is a Feature, Not a Compromise
Market-cap-weighted all-in-one funds own stocks in proportion to their size in the global market. This makes them easy to understand, easy to explain to a skeptical spouse, and easy to hold through turbulence without second-guessing the underlying logic. When VEQT fell during a tariff-driven market scare, the right response was straightforward: global stocks have recovered from worse disruptions, the expected return assumption hasn’t changed, and selling requires being right twice — once on the way out and once on the way back in. That clarity of reasoning is harder to maintain when a fund is also lagging a simpler alternative for reasons related to factor timing rather than broad market conditions.
None of this means factor-tilted funds are a bad product. CAGE appears well-constructed for investors who genuinely understand what they are buying: a plausible but uncertain edge, with higher tracking error, that requires patience measured in decades rather than quarters. For that investor, it may be a reasonable choice — better, at least, than building a multi-ETF factor portfolio from scratch.
But most DIY investors shopping for a single all-in-one fund are not primarily asking "how do I maximize theoretical expected return?" They are asking "how do I build wealth steadily without making costly mistakes?" For that question, the additional complexity of a factor tilt adds a new source of doubt and a new reason to tinker. Simplicity removes those temptations. That is not a small thing.
The Question Worth Asking
A smart evaluation of any investment product asks not only whether a strategy might beat the market, but what it costs, how it can fail, and whether the investor can stay the course through the failure. A fund launch tells you nothing about whether the strategy will work going forward. Avantis’s suggestion of 2% annual outperformance is a marketing point derived from historical factor data — not a forward-looking commitment, and not an established result for this specific product in its current fee structure and market environment.
Factor tilts may offer a plausible long-run premium. They do not offer certainty, they do not eliminate the cost of patience, and they do not relieve the investor of the hardest part of investing: holding steady when the strategy looks wrong. For the investor who can genuinely embrace that tradeoff, CAGE is an interesting option. For everyone else, the plain haystack is not a lesser choice — it may simply be the more honest one.
This article is educational and does not recommend any specific ETF. Past outperformance of any strategy, if any, does not ensure future results.
